Jerome Custers

5.0k citations
33 papers · 2.3k · 1 hit paper · h-index 20

Impact in

  • Genetics top 1%
    • Virus-based gene therapy research
  • Infectious Diseases top 2%
    • Viral gastroenteritis research and epidemiology
    • Viral Infections and Outbreaks Research

Papers in

  • Genetics 23
    • Virus-based gene therapy research 23
  • Molecular Biology 17
    • Viral Infectious Diseases and Gene Expression in Insects 10
    • RNA Interference and Gene Delivery 4
Co-authors
Menzo Havenga (11 shared papers)Jaap Goudsmit (11 shared papers)Maarten H. Stuiver (3 shared papers)Dan H. Barouch (5 shared papers)Andrew H. Baker (8 shared papers)Stuart A. Nicklin (5 shared papers)Alan L. Parker (4 shared papers)John H. McVey (4 shared papers)
Journals
Vaccine (8 papers)Journal of Virology (4 papers)Journal of General Virology (4 papers)Human Gene Therapy (3 papers)The Journal of Immunology (2 papers)
Partner nations
NetherlandsUnited StatesUnited Kingdom

In The Last Decade

Jerome Custers

33 papers receiving 2.2k citations

Jerome Custers's Hit Papers

Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer 2008 · 527 citations
5270+6+12Years since publication100200300400500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2008 Cell

Peers

Jerome Custers
Comparison fields: 5 of 91
  • Genetics 1.3k
  • Infectious Diseases 762
  • Virology 143
  • Oncology 533
  • Molecular Biology 1.0k
Replace Jason G. Gall with:
Jason G. Gall United States
Lennart Holterman Netherlands
Gerald W. Both Australia
Drew L. Lichtenstein United States
Jerry L. Blackwell United States
Marcio O. Lasaro United States
Eric A. Weaver United States
Sarah K. Wootton Canada
Niklas Arnberg Sweden
Colomba Giorgi Italy
Jerome Custers relative to Jason G. Gall United States Jason G. Gall's profile →
Citations per field
00.5×2×3×3.5×
Jason G. Gall · 1×
Citations per year

Countries citing papers authored by Jerome Custers

Since Specialization
Citations

This map shows the geographic impact of Jerome Custers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Custers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Custers more than expected).

Fields of papers citing papers by Jerome Custers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome Custers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Custers. The network helps show where Jerome Custers may publish in the future.

Co-authors

The 25 scholars most cited alongside Jerome Custers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jerome Custers Line = papers co-authored together Jerome Custers links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
Cell ·Simon N. Waddington, John H. McVey, David Bhella, Alan L. Parker, Kristeen Barker, Hideko Atoda, Rebecca Pink, Suzanne M. K. Buckley, Jenny A. Greig, Laura Denby, Jerome Custers, Takashi Morita, Ivo M.B. Francischetti, Robson Q. Monteiro, Dan H. Barouch, Nico van Rooijen, Claudio Napoli, Menzo Havenga, Stuart A. Nicklin, Andrew H. Baker
Hit paper breakdown →		2008527
2
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
The Journal of Immunology ·Dan H. Barouch, Maria Grazia Pau, Jerome Custers, Wouter Koudstaal, Stefan Kostense, Menzo Havenga, Diana M. Truitt, Shawn M. Sumida, Michael Kishko, Janelle C. Arthur, Birgit Korioth-Schmitz, Michael H. Newberg, Darci A. Gorgone, Michelle A. Lifton, Dennis Panicali, Gary J. Nabel, Norman L. Letvin, Jaap Goudsmit
2004330
3
Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein
The Journal of Immunology ·Shawn M. Sumida, Diana M. Truitt, Angelique A. C. Lemckert, Ronald Vogels, Jerome Custers, Marylyn M. Addo, Shahin Lockman, Trevor Peter, Fred W. Peyerl, Michael Kishko, Shawn S. Jackson, Darci A. Gorgone, Michelle A. Lifton, (unknown), Bruce D. Walker, Jaap Goudsmit, Menzo Havenga, Dan H. Barouch
2005305
4
Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs
PLoS Medicine ·Nancy J. Sullivan, Thomas W. Geisbert, Joan B. Geisbert, Devon J. Shedlock, Ling Xu, Laurie Lamoreaux, Jerome Custers, Paul M. Popernack, Zhiyong Yang, Maria Grazia Pau, Mario Roederer, Richard A. Koup, Jaap Goudsmit, Peter B. Jahrling, Gary J. Nabel
2006159
5
Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5
Journal of Virology ·Lennart Holterman, Ronald Vogels, Remko van der Vlugt, Martijn Sieuwerts, Jos Grimbergen, Jorn Kaspers, Eric Geelen, Esmeralda van der Helm, Angelique A. C. Lemckert, Gert Gillissen, Sandra Verhaagh, Jerome Custers, David Zuijdgeest, Ben Berkhout, Margreet Bakker, Paul H.A. Quax, Jaap Goudsmit, Menzo Havenga
2004125
6
Engineering disease resistance in plants
Nature ·Maarten H. Stuiver, Jerome Custers
2001114
7
Isolation and characterisation of a class of carbohydrate oxidases from higher plants, with a role in active defence
The Plant Journal ·Jerome Custers, Stuart J. Harrison, Marianne B. Sela‐Buurlage, Els van Deventer, Wessel Lageweg, Peter W. A. Howe, Pieter J. Van Der Meijs, Anne Ponstein, Bert H. Simons, Leo S. Melchers, Maarten H. Stuiver
2004109
8
Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity toPlasmodium falciparumCS Compared to That with Either Malaria Vaccine Alone
Infection and Immunity ·V. Ann Stewart, Shannon McGrath, Patrice Dubois, Maria Grazia Pau, Pascal Mettens, Joseph P. Shott, Michelle Cobb, J. Robert Burge, David Larson, Lisa A. Ware, Marie‐Ange Demoitié, Gerrit Jan Weverling, Babak Bayat, Jerome Custers, Marie‐Claude Dubois, Joe Cohen, Jaap Goudsmit, D. Gray Heppner
200781
9
Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer
Journal of Virology ·Alan L. Parker, Simon N. Waddington, Suzanne M. K. Buckley, Jerome Custers, Menzo Havenga, Nico van Rooijen, Jaap Goudsmit, John H. McVey, Stuart A. Nicklin, Andrew H. Baker
200870
10
Challenges in Manufacturing Adenoviral Vectors for Global Vaccine Product Deployment
Human Gene Therapy ·Jort Vellinga, J. Patrick Smith, Agnieszka Lipiec, Dragomira Majhen, Angelique A. C. Lemckert, Mark van Ooij, P. M. Ives, Christopher Yallop, Jerome Custers, Menzo Havenga
201469
11
Ad5:Ad48 Hexon Hypervariable Region Substitutions Lead to Toxicity and Increased Inflammatory Responses Following Intravenous Delivery
Molecular Therapy ·Lynda Coughlan, Angela C. Bradshaw, Alan L. Parker, H. G. Robinson, Katie White, Jerome Custers, Jaap Goudsmit, Nico van Roijen, Dan H. Barouch, Stuart A. Nicklin, Andrew H. Baker
201247
12
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment
Vaccine ·Jerome Custers, Denny Kim, Maarten Leyssen, Marc Gurwith, Frank Tomaka, James S. Robertson, Esther Heijnen, Richard Condit, Georgi Shukarev, Dirk Heerwegh, Roy van Heesbeen, Hanneke Schuitemaker, Macaya Douoguih, Eric Evans, Emily Smith, Robert T. Chen
202046
13
PER.C6® cells as a serum-free suspension cell platform for the production of high titer poliovirus: A potential low cost of goods option for world supply of inactivated poliovirus vaccine
Vaccine ·Barbara P. Sanders, Diana Edo-Matas, Jerome Custers, Martin H. Koldijk, Vincent Klaren, Marije Turk, Alfred Luitjens, Wilfried A.M. Bakker, F. G. C. M. UytdeHaag, Jaap Goudsmit, John A. Lewis, Hanneke Schuitemaker
201240
14
Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo
PLoS Pathogens ·Jiangtao Ma, Margaret R. Duffy, Lin Deng, Rachel Dakin, Taco G. Uil, Jerome Custers, Sharon M. Kelly, John H. McVey, Stuart A. Nicklin, Andrew H. Baker
201538
15
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys
Vaccine ·Ariane Rodrı́guez, Ratna Mintardjo, Dennis Tax, Gert Gillissen, Jerome Custers, Maria Grazia Pau, J. Klap, Sampa Santra, Harikrishnan Balachandran, Norman L. Letvin, Jaap Goudsmit, Katarina Radošević
200930
16
αvβ3 Integrin Is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26
Journal of Virology ·Davor Nestić, Taco G. Uil, Jiangtao Ma, Soumitra Roy, Jort Vellinga, Andrew H. Baker, Jerome Custers, Dragomira Majhen
201828
17
Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine
PLoS Pathogens ·Barbara P. Sanders, Isabel de los Rios Oakes, Vladimir van Hoek, Viki Bockstal, Tobias Kamphuis, Taco G. Uil, Yutong Song, Gillian Cooper, Laura Crawt, Javier Martín, Roland Zahn, John A. Lewis, Eckard Wimmer, Jerome Custers, Hanneke Schuitemaker, Jerónimo Cello, Diana Edo-Matas
201626
18
Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease
International Journal of Cancer ·Selina Khan, Koen Oosterhuis, Kerstin Wunderlich, Evelien M. Bunnik, Melissa Bhaggoe, Satish Boedhoe, Santusha Karia, Renske D.M. Steenbergen, Leontien Bosch, Jan Serroyen, Sarah Janssen, Hanneke Schuitemaker, Jort Vellinga, Gert C. Scheper, Roland Zahn, Jerome Custers
201725
19
Suitability of PER.C6® cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics
Vaccine ·Wouter Koudstaal, Lorian C. Hartgroves, Menzo Havenga, Isabelle Legastelois, C. Ophorst, Martijn Sieuwerts, David Zuijdgeest, Ronald Vogels, Jerome Custers, Els de Boer-Luijtze, O de Leeuw, Lisette A. H. M. Cornelissen, Jaap Goudsmit, William Barclay
200922
20
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses
Vaccine ·Marija Vujadinovic, Selina Khan, Koen Oosterhuis, Taco G. Uil, Kerstin Wunderlich, Sarra Damman, Satish Boedhoe, Annemiek Verwilligen, Jonathan Knibbe, Jan Serroyen, Hanneke Schuitemaker, Roland Zahn, Gert C. Scheper, Jerome Custers, Jort Vellinga
201820

About Jerome Custers

Jerome Custers is a scholar working on Genetics, Molecular Biology, Infectious Diseases, Oncology and Epidemiology, having authored 33 papers that have together received 2.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (23 papers), CAR-T cell therapy research (10 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers), Viral gastroenteritis research and epidemiology (9 papers), Viral Infections and Immunology Research (6 papers), RNA Interference and Gene Delivery (4 papers), Herpesvirus Infections and Treatments (3 papers) and Plant-Microbe Interactions and Immunity (3 papers). The work is most often cited by research in Genetics (1.3k citations), Infectious Diseases (762 citations), Virology (143 citations), Oncology (533 citations) and Molecular Biology (1.0k citations). Jerome Custers has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Menzo Havenga, Jaap Goudsmit, Maarten H. Stuiver, Dan H. Barouch, Andrew H. Baker, Stuart A. Nicklin, Alan L. Parker, John H. McVey, Maria Grazia Pau and Michael Kishko. Their work appears in journals such as Vaccine, Journal of Virology, Journal of General Virology, Human Gene Therapy and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason G. GallBreakdown of academic impact, for papers by Lennart HoltermanBreakdown of academic impact, for papers by Gerald W. BothBreakdown of academic impact, for papers by Drew L. LichtensteinBreakdown of academic impact, for papers by Jerry L. BlackwellBreakdown of academic impact, for papers by Marcio O. LasaroBreakdown of academic impact, for papers by Eric A. WeaverBreakdown of academic impact, for papers by Sarah K. WoottonBreakdown of academic impact, for papers by Niklas ArnbergBreakdown of academic impact, for papers by Colomba Giorgi